Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01430403
Show Display Options
Rank Status Study
1 Completed Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations
Condition: Asthma
Interventions: Biological: Omalizumab;   Drug: Fluticasone;   Biological: Placebo omalizumab;   Biological: Placebo fluticasone

Indicates status has not been verified in more than two years